Guardian Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.76M Sell
181,975
-22,111
-11% -$988K 0.7% 44
2026
Q1
$9.86M Buy
204,086
+1,026
+0.5% +$47.8K 0.82% 38
2025
Q4
$9.73M Buy
203,060
+20,614
+11% +$1.02M 0.78% 40
2025
Q3
$9.08M Buy
182,446
+698
+0.4% +$33.7K 0.77% 45
2025
Q2
$8.87M Sell
181,748
-1,737
-0.9% -$88.8K 0.8% 40
2025
Q1
$9.73M Sell
183,485
-2,624
-1% -$142K 1.01% 33
2024
Q4
$9.16M Buy
+186,109
New +$9.46M 0.93% 40

Other funds holding SNY

Guardian Partners's SNY Position: Q2 2026 in Review

Guardian Partners reduced its Sanofi (SNY) stake by 11% in Q2 2026, selling an estimated $988K and leaving 181,975 shares worth $7.76M. The position accounts for 0.7% of the portfolio, ranked #44.

Guardian Partners first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.86M in Q1 2026. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Guardian Partners held 181,975 shares of Sanofi worth $7.76M as of Q2 2026.
  • Guardian Partners sold 22,111 Sanofi shares in Q2 2026, an estimated $988K.
  • Sanofi made up 0.7% of Guardian Partners's portfolio in Q2 2026, its #44 holding.
  • Guardian Partners first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Guardian Partners's Sanofi position peaked at $9.86M in Q1 2026.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.